IFN-g is known to be predominantly produced by lymphoid cells such as certain subsets of T cells, NK cells, and other group 1 innate lymphoid cells. In this study, we used IFN-g reporter mouse models to search for additional cells capable of secreting this cytokine. We identified a novel and rare population of nonconventional IFN-g-producing cells of hematopoietic origin that were characterized by the expression of Thy1.2 and the lack of lymphoid, myeloid, and NK lineage markers. The expression of IFN-g by this population was higher in the liver and lower in the spleen. Furthermore, these cells were present in mice lacking both the Rag2 and the common g-chain (gc) genes (Rag2 2/2 gc 2/2 ), indicating their innate nature and their gc cytokine independence. nterferon-g is a proinflammatory cytokine that plays a major role in protective immune responses against intracellular pathogens. Upon infection, phagocytes will respond by producing cytokines such as IL-12 and IL-18, which will induce NK cells and invariant NK T cells to release IFN-g during the innate phase of the immune response. At later stages, CD4 + and CD8 + T cells are primed to produce IFN-g and contribute to pathogen clearance (reviewed in Ref. 1) . The major cellular targets of IFN-g are mononuclear phagocytes that are activated to upregulate Ag processing and presentation pathways, lysosomal activity, and reactive species production, which in turn mediate the microbicidal effect (1, 2) . IFN-g is also responsible for inducing leukocyte recruitment to the infection site and generation of granulomatous lesions, such as the ones induced by mycobacterial infections (1) , wherein the newly recruited leukocytes are able to produce more IFN-g as well as other cytokines that will directly act on the infected cells. Ab-mediated or genetic ablation of IFN-g signaling severely compromises the in vivo assembly of granulomas in mycobacterial infections (3) (4) (5) . Complete lack of IFN-g signaling, such as found in gene-deleted mice, leads to an increased susceptibility to infection relative to that seen when only IFN-g-producing T cells are lacking (6) (7) (8) (9) . NK cells are efficient producers of IFN-g (1, 10) and have been associated with IFN-gmediated protection, particularly in the absence of T cells (11, 12) . However, mice that lack B and T cells, NK cells, and the other innate lymphoid cells (ILCs), as a result of the deletion of the Rag enzyme required for TCR and BCR recombination and the IL-2R common g-chain (gc), are more resistant to Chlamydia pneumoniae than Rag1 2/2 IFN-g 2/2 double-knockout mice (13) . In addition, the authors showed that both Rag1 2/2 and Rag1 2/2 gc 2/2 express equivalent levels of Ifng mRNA and protein in infected lungs. These data suggest, therefore, the existence of an additional cellular source of IFN-g. Indeed, several reports propose the existence of nonconventional IFN-g-producing cells. Infection with Escherichia coli or Listeria monocytogenes induces IFN-g production by splenic innate B cells, which in turn promotes an innate response against these bacteria (14) . Human oral epithelial cells have also been shown to produce IFN-g upon in vitro infection with Candida albicans (15) . Expression or secretion of IFN-g has been detected in peritoneal or splenic macrophages and in bone marrow-derived macrophages or dendritic cells after in vitro stimulation with IL-12/IL-18 or infection with different pathogens (C. pneumoniae, Salmonella typhimurium) (16) (17) (18) (19) (20) (21) . However, a more detailed study revealed that the lack of purity of the myeloid cells casts doubt upon macrophages as the source of the IFN-g (22, 23) . More recently, work from Sturge et al. (24) identified peritoneal neutrophils as an IL-12-independent source of IFN-g in response to Toxoplasma gondii.
To identify novel cellular sources of IFN-g, we used reporter mouse models and describe in this article a rare population of IFN-g-expressing CD45 + Thy1.2 + cells that are of nonlymphoid, nonmyeloid, and non-NK lineage. Moreover, we provide experimental evidence that these cells are functionally relevant, conferring protection against M. avium infection in the liver of lymphopenic Rag2 2/2 gc 2/2 (lacking both the Rag2 and the common gc genes)
mice.
Materials and Methods

Animals
YFP-enhanced transcript for IFN-g (Yeti) mice were crossed with C57BL/ 6.Rag1 2/2 mice at the Trudeau animal house facilities. Yeti mice were generated by the introduction of an IRES-enhanced YFP construct after the stop codon of IFN-g and is under the control of a bovine growth hormone polyA tail (25) . The IFN-g reporter with endogenous polyA tail (Great) mice (C57BL/6 background) have the IFN-g-IRES-enhanced YFP reporter cassette under the control of the endogenous ifng 39 untranslated region and polyA tail (25) . All procedures involving live animals were performed in accordance with the Guide for Care and Use of Laboratory Animals of the National Institutes of Health, and individual procedures were approved by the Trudeau Institute Animal Care and Use Committee. C57BL/6.IFN-g 2/2 mice were purchased from Jackson Laboratories (Bar Harbor, ME), and C57BL/6.Rag2 2/2 mice were obtained from the Centre de Développement des Techniques Avancées pour l'expérimenta-tion animale (Orleans, France). The two strains were crossed at Instituto de Biologia Molecular e Celular animal facilities to obtain double-mutant mice. Double-knockout mice were screened by performing PCR with IFN-g gene-specific primers (according to Jackson Laboratories) from genomic DNA extracted from an ear clipping and by performing flow cytometric analysis of blood samples to detect lymphopenic mice. Mice deficient in both Rag2 and the common gc (B6.Rag2
.gc 2/2 ) were provided by Dr. J. di Santo. Animal care procedures were in accordance with institutional guidelines. This study was previously approved by the Portuguese National Authority for Animal Health-Direcção Geral de Veterinária.
Infection and Ab administration
Mice were infected with Mycobacterium avium strain 2447 by injecting 10 6 CFUs i.v. At different times of infection, mice were sacrificed and the bacterial burden was determined in the major target organs, the spleen and the liver, by plating serial dilutions of tissue homogenates onto Middlebrook 7H10 medium (Difco, St. Louis, MO). In two experiments, infected Rag2 
Flow cytometry
Liver and spleen cells were isolated from naive or infected animals. In brief, a single cell suspension was prepared from the spleen or liver by passing the organ through a 70-mm nylon cell strainer, followed by treatment with RBC lysis buffer. Liver cells were further subjected to a 40%:80% Percoll (GE Healthcare) gradient to isolate the mononuclear cells. Cells were washed and the number of viable cells was counted by trypan blue exclusion. For the immunofluorescence staining of cells from Rag1
2/2
.Yeti and Great mice, cells were incubated for 20 min with saturating concentrations of the different combinations of the following Abs: Ly6G-PB, CD90.2-V500, CD11c-PE, CD45-PE-Texas Red, TCRb-PerCP/Cy5.5, TCRgd-PerCP/Cy5.5, CD19-PerCP/Cy5.5, CD11b-PE/Cy7, NK1.1-allophycocyanin, NKp46-allophycocyanin, CD49b-allophycocyanin, Ly6C-Alexa Fluor 700, F4/80-allophycocyanin eFluor780, CD11c-eFluor 450, and CD11b-e.Fluor 450. For the transcription factors analysis, after the surface staining, cells were processed for intracellular staining using the eBioscience "Transcription factor staining buffer set" according to the manufacturer's instructions and then stained for RORgt-PE, and Tbet-PE/Cy7. Samples were collected using Diva software on an LSRII flow cytometer (BD Biosciences).
Cells from Rag2 2/2 , Rag2 2/2 gc 2/2 , and Rag2 2/2 IFN-g 2/2 mice were stained with the different combinations of the following Abs: CD4-V450, CD11c-BV421, CD3-V500, CD8-V500, CD11b-BV510, CD90.2-FITC, NK1.1-FITC, NKp46-FITC, CD49b-FITC, CD90.2-PE, CD45-PerCP/ Cy5.5, Sca-1-PerCP/Cy5.5, CD122-PE/Cy7, CD127-PE-Cy7, CD11b-eFluor 660, CD11c-eFluor 660, IA/IE-allophycocyanin, F4/80-AF647, Ly6G-A6F47,CD25-allophycocyanin/Cy7, and F4/80-allophycocyanin/Cy7. For the intracellular IFN-g flow cytometry analysis, total spleen cells or total mononuclear liver cells were stimulated with PMA, Ionomycin, and brefeldin A for 5 h at 37˚C. After cell surface staining, cells were fixed with 2% paraformaldehyde and permeabilized with 0.5% saponin. Cells were then incubated with IFN-g-PE/Cy7 or the isotype-matched control for 20 min at room temperature. After two washing steps, cells were acquired by flow cytometry in a FACSCanto II cytometer (BD Biosciences) using a BD FACSDiva software. All data were analyzed using FlowJo software (Tree Star).
Cell sorting
Liver mononuclear cells prepared as described earlier were pooled from three to four naive or infected Rag1 2/2 animals and sorted in a BD Influx, 11-color, four-laser system and separated into three different cell populations based on the expression of CD45 /nonmyeloid cells). These experiments were conducted in a FACSAria using FACSDiva software. The separation purity of all experiments was always confirmed and superior to 94%. Cells were sorted into RLT buffer (RNeasy Micro Kit from Qiagen) for posterior RNA purification.
Imaging flow cytometry
Liver mononuclear cells from Rag2 2/2 or Rag2 2/2 gc 2/2 mice were prepared as described earlier and stained either for surface phenotyping or intracellular IFN-g detection. Cellular events were acquired using the ImageStream (Amnis; EDM Millipore, Darmstadt, Germany) imaging flow cytometer, and the multiple image analysis was performed using the IDEAS software (v6.0.348, Amnis; EDM Millipore).
RNA extraction and real-time RT-PCR
Total RNA was extracted from sorted populations (RNeasy Micro kit; Qiagen) according to the manufacturer's instructions. RNA was reverse transcribed to cDNA, using the SuperScript III First-Strand Synthesis System for RT-PCR (Invitrogen) and Random Hexamers (Fermentas), and real-time PCR (iCycler iQ5; Bio-Rad) was performed using TaqMan Universal PCR Master Mix and primers specific for Hprt, Ifng, Id2, and Zbtb16 (Applied Biosystems) according to the manufacturer's protocols. Triplicate samples were analyzed, and the DDCt method was used to calculate relative levels of targets compared with Hprt. Data were analyzed using iQ5 Optical System software (Bio-Rad).
Histological and morphometric analysis
Tissues samples were fixed in buffered formalin, embedded, and processed for histology by staining with H&E. Slides were photographed using an Olympus CX31 light microscope equipped with a DP-25 camera (Imaging Software Cell^B; Olympus, Center Valley, PA). One liver section per animal with random fields selected in a blind way was analyzed. The determination of the infiltration area was done in a total tissue area ranging from 6 3 10 6 to 9 3 10 6 mm 2 , corresponding to five fields analyzed in each section. To determine the liver area covered by cellular infiltrations, we used the National Institutes of Health ImageJ software program. The percentage of infiltrated area was calculated by dividing the cumulative area of cell infiltration by the total liver surface of each image.
Immunofluorescence
Liver tissues were fixed in 4% paraformaldehyde, washed in PBS, incubated for 2 h in a 30% sucrose solution and embedded in optimal cutting temperature compound (OCT), and stored at 280˚C until sectioning. Tissue sections (10 mm thickness) were performed in a frozen cryostat and stored at 220˚C until use. Slides were saturated in blocking solution (10% FBS, 0.1% Triton X-100 in PBS) for 1 h at room temperature. Rabbit polyclonal IgG specific for inducible NO synthase (iNOS; M-19; Santa Cruz Biotechnology) and rat monoclonal CD90.2 (Thy1.2) (53-21; BD Pharmingen) Abs were diluted in Ab dilution buffer (1% FBS, 0.1% Triton X-100 in PBS) and incubated overnight with tissue sections at 4˚C. After washing, sections were incubated with Alexa 647 goat anti-rabbit IgG and Alexa Fluor 488 goat anti-rat IgG Abs (Life Technologies) for 1 h at room temperature. Sections were then counterstained and mounted with DAPIFluoroshield and imaged in a Leica DMI 6000B inverted microscope using the ORCA-Flash4.0 version 2 (Hamamatsu Photonics) CMOS camera. Images were further analyzed and processed using ImageJ.
Statistical analysis
Results were expressed as means 6 1 SD. Statistical significance was calculated by using the unpaired Student t test or the one-way ANOVA test with a Tukey posttest. A p value ,0.05 was considered statistically significant.
Results
IFN-g is expressed in nonconventional Thy1.2 + cells that lack T, NK, and myeloid lineage markers
The evidence of a T cell-and NK cell-independent IFN-g-mediated immunity was suggested before by our group (9) and others (6, 13, 26). Hence, to identify a non-T, non-NK cell source of IFN-g, we used an IFN-g-YFP reporter mouse (Yeti) backcrossed with Rag1 (nonreporter) animals (Fig. 1B) . Although ifng gene expression was detected in NK cells, no Ifng expression was detected in sorted myeloid cells. The non-NK/nonmyeloid Thy1.2 + cells exhibited the same levels of constitutive ifng gene expression as the NK cell subset (Fig. 1C) , confirming the flow cytometry data. Despite the negative results for the myeloid cells, and because these cells have been reported as possible sources of IFN-g (16-21, 24), we decided to further ascertain the capacity of myeloid cells, namely macrophages, to express IFN-g. To do so, we subjected bone marrowderived macrophages from C57BL/6 animals to different polarizing stimuli and tested whether the different polarizations could dictate the capacity to express IFN-g. No Infg gene expression was detected in any of the macrophage subsets despite their ability to express other cytokines (Supplemental Fig. 1) .
Because the IFN-g-YFP mRNA in Yeti animals is stabilized by a bovine growth hormone polyA tail, it leads to an aberrant expression of IFN-g (25) , as confirmed in this study in the Rag1 2/2 .
Yeti mice, which had around 70% YFP + cells in the liver and 60% in the spleen (Fig. 1A) . To ascertain whether our previous results were not an artifact of the Yeti mouse model, we used another reporter mouse where the IFN-g-YFP mRNA is under control of the endogenous IFN-g polyA tail (Great mice, IFN-g reporter with endogenous polyA transcript) in a C57BL/6 background, that is, with no deletion of Rag. The frequency of the YFP + cells in this mouse model was around 17% in the liver and 2% in the spleen (Supplemental Fig. 2A) An even higher percentage of these cells was found to express YFP (Supplemental Fig. 2B) , and a population of Thy1.2 + /non-NK/non-T/non-B cells was identified in the liver and spleen of Great mice (Fig. 2A) . In the livers, 50% of these Thy1.2 + /NK 2 cells expressed YFP, slightly more than the NK cells (around 40%) (Fig. 2B) . In contrast, in the spleen, the frequency of YFP + cells within the Thy1.2 + /non-NK population was low (around 2%). The cell number analysis reflected these differences: despite the higher Thy1. (Fig. 2C) . Further, analysis of these Thy1.2 + non-NK cells revealed that, in addition to being F4/80 2 , they also lacked the expression of CD11b, CD11c, and Ly6G, confirming their nonmyeloid origin, and a small subset of these cells (17.7% in the liver and 33.4% in the spleen) express Ly6C, whereas the rest do not (Fig. 2D) . Despite the substantial difference in YFP expression, both the liver and the spleen populations had a similar phenotype. Moreover, the majority of the Thy1.2 + /non-NK cells in the liver expressed T-bet (∼72%), a
The Journal of Immunologymaster regulator in IFN-g-producing cells, and a small fraction of these cells expressed RORgt, in contrast with NK cells, which were all T-bet + and RORgt 2 (Fig. 2E) . The spleen presented a similar transcription factor pattern, although the frequency of T-bet + cells was much lower, paralleling the lower YFP expression.
CD45
+ Thy1.2 + cells with a non-T, non-NK, and nonmyeloid phenotype are found in common gc-deficient mice
We then asked whether the development of nonconventional IFNg-expressing Thy1. (Fig. 3A) . The absence of CD68 expression confirmed their nonmyeloid origin (Supplemental Fig. 2C ). To ascertain whether these cells express IFN-g, we assessed gene expression by quantitative PCR (qPCR) on sorted Thy1.2 + nonmyeloid cells and also on myeloid + (CD11b + and/or CD11c + ) cells from both the liver and the spleen (Fig. 3B) . A significant expression of the Ifng gene was detected in sorted Thy1.2 + nonmyeloid cells in the liver, whereas no Ifng expression was detected in the spleen. These findings are in agreement with the very low levels of IFN-g-YFP detected by cytometry in the spleens of the Great reporter mice (Fig. 2B, 2C ) and support the existence of these cells in the absence of reporter gene insertion in the Ifng locus. No Ifng gene expression was detected on myeloid cells (Fig. 3B) , but it was found in sorted NK cells from Rag2 2/2 mice (Supplemental Fig. 3A ). marker of NK cell precursors, and a fraction of them expressed MHC class II. Moreover, the majority of these cells express CD127 (IL-7Ra) and Sca-1, with a small fraction expressing low levels of CD25 (Fig. 3C) . Further analysis revealed that these cells lacked CD3 and CD8, and in the absence of the gc chain they expressed CD4 (Supplemental Fig. 2E) . Interestingly, the expression of both CD127 and CD4 were lower when the gc chain signaling was present (Rag2 2/2 mouse). In fact, the CD4 expression was totally abolished in cells of the liver of Rag2 Fig. 2F ).
The lack of IFN-g, but not of the common gc, exacerbated the infection and compromised the development of granulomas in a Rag-deficient background
To assess the biological relevance of this rare population of IFN-gproducing Thy1
+ cells, we used a model of M. avium infection. We have previously shown that susceptibility of SCID mice to M. avium could be exacerbated by the Ab-mediated neutralization of IFN-g, suggesting an innate source for this cytokine (9) . SingleAb depletions of NK cell subsets (e.g., asialo-GM1 + or Thy1 + ) were ineffective at achieving the same exacerbation but were incomplete in their ability to deplete NK cells in SCID mice, suggesting a redundant role for different populations of innate cells in the small but statistically significant protection afforded by IFN-g in the absence of T cells (9) . In this study, we found increased bacterial loads in the livers and spleens of B6.IFN-g 2/2 mice compared with the C57BL/6 control, as well as in the Rag2
IFN-g 2/2 double-knockout animals when compared with the Rag2 2/2 mice (Fig. 4A, Supplemental Fig. 4A ). In contrast,
Rag2
2/2 gc 2/2 animals were as able to control the bacterial proliferation (although the latter with a much lower number) (data not shown). In addition, the lower CFU values observed particularly in the spleens of the different Rag-deficient strains 30 dpi as compared with the Ragsufficient strains were due to a lower inoculum implantation at the start of the infection because of the very small size of the organ in these animals. Granuloma assembly is highly dependent on IFN-g production and is one of the main histopathological features of mycobacterial infections. C57BL/6 mice showed the largest cell infiltration areas, and their granulomas were well developed. The number of lesions in infected IFN-g 2/2 or Rag2 2/2 IFN-g 2/2 mouse liver controls was smaller and lacked the prototypical organization of the inner macrophage core. Instead, they just consisted of lymphoid cell accumulations (Fig. 4B, 4C ). In contrast, the livers of infected Rag2 2/2 and Rag2 2/2 gc 2/2 mice showed granulomatous structures with a well-developed macrophage core and higher number of lesions (Fig. 4B, 4C ). Despite the extremely low number of the Thy1.2 + /non-NK cells in naive Rag2 2/2 gc 2/2 mice, their number increased sharply during the course of the infection, with a 10-fold increase in the liver and a 20-fold increase in the spleen at 60 d of infection (Fig. 5A) . Strikingly, these cells could be found by immunofluorescence microscopy within the granulomatous lesions in the liver adjacent to macrophages that expressed iNOS, an enzyme known to be induced by IFN-g (Fig. 5B) and that was also found to be induced in the livers of infected Rag2 2/2 mice (data not shown).
Next, we measured IFN-g protein in liver and spleen mononuclear cells stimulated with PMA/Ionomycin and brefeldin A (Fig. 5C shown in Fig. 5D ). As control, IFN-g was also detected in NK cells from Rag2
-infected mice (Fig. 5C, 5D ). These findings are in accordance with the data obtained with the IFN-g reporter animals (Figs. 1A, 2B ) and the Ifng gene expression in the sorted Thy1.2 + /non-NK cells (Fig. 3B, Supplemental Fig. 3B ) from Rag2 (Fig. 6A) . Although no differences in the bacterial proliferation were observed in the spleens of anti-Thy1.2-treated versus control animals, the Ab depletion reverted the 2-fold decrease in liver mycobacterial loads observed in Rag2 2/2 gc 2/2 mice when compared with an IFN-gdeficient host (Fig. 6B) . These results suggest that the Thy1.2 + IFN-g-producing cells can functionally participate in the immune response against M. avium.
Discussion
The most important producers of IFN-g in the mammalian organism are T lymphocytes and NK cells. B cells, epithelial cells, but more consistently myeloid cells, such as macrophages, DCs, and neutrophils, have also been reported as capable of producing this cytokine (14-21, 24) . Recently, ILCs distinct from NK cells , Rag2
, Rag2 and named type 1 and type 3 ILCs were shown to express IFN-g and to participate in the response to infection and inflammation (27) (28) (29) . Based on our previous work, where we found T cell-and NK cell-independent IFN-g-mediated immunity (9), we used IFN-g reporter mice to look for additional IFN-g-producing cells.
Using flow cytometry, we found a small population of CD45 + Thy1.2 + non-T, non-B, non-NK, and nonmyeloid cells that expressed YFP in two distinct reporter strains. The IFN-g-YFP expression by these cells was particularly evident in the liver, whereas in the spleen the expression was rather low. A cellular population with a similar phenotype was found in nonreporter Rag-deficient mice. These latter cells expressed IFN-g as confirmed by qPCR. These cells were also found in mice that lack both the expression of Rag and the common gc of the IL-2R. Because the latter is required for the generation of NK cells and all the other ILCs, further studies should address whether this new population may represent a distinct or precursor lineage of innatelike cells. In contrast, the fact that these cells are CD127 + (IL-7Ra + ) and are present in very small numbers in the absence of gc suggests that the signaling via the IL-7Ra/gc heterodimer may be important for their development. Supporting this hypothesis are the increased numbers of these cells in immune-competent mice (C57BL/6.Great), where the presence of gc allows the signaling via IL-7Ra. Alternatively, the IL-7Ra could form a heterodimer complex with the thymic stromal lymphopoietin receptor for thymic stromal lymphopoietin signaling, as shown during the induction of Th2 responses (30, 31) . A further possibility is that the cells found in Rag2 (35) show that the discrimination between ILC1 and NK cells can be trickier in the spleen than the liver, because of the fact that these cells express different surface markers in these organs.
To understand the physiological relevance of the IFN-g-producing Thy1.2 + /non-NK cells, we explored their role in an experimental M. avium infection model because the control of this opportunistic pathogen is strictly dependent on IFN-g (3-5, 36, 37) . In the absence of T cells, the major producers of IFN-g, Rag-deficient mice were still more resistant than mice lacking both Rag and IFN-g, suggesting a T cell-independent source of this molecule. We also observed that both Rag2 2/2 and Rag2 2/2 gc 2/2 mice were able to control the bacterial growth more efficiently than Rag2 2/2 IFN-g 2/2 mice. These results exclude NK cells as the sole source of IFN-g in the absence of T cells and suggest the existence of a redundant source for this cytokine. During M. avium infection, we observed an increase in the numbers of a novel CD45 + Thy1.2 + non-NK and nonmyeloid IFN-g-producing population of cells. The ability of these infected cells to produce IFN-g protein was also confirmed by intracellular staining after PMA/ Ionomycin stimulation. Importantly, these cells were found to localize within granulomatous lesions in the liver in the vicinity of cells staining positive for iNOS, which is most frequently induced by IFN-g. Further, Thy1.2-specific mAb-mediated cell depletion increased the pathogen growth in the liver of Rag2 2/2 gc 2/2 mice to the levels of Rag2 2/2 IFN-g 2/2 animals while reducing the cell infiltration area. Together, our data demonstrate that this nonconventional population of IFN-g-producing cells accumulates in the liver, within the granuloma, and mediates improved control of bacterial growth. These cells were not frequent in the spleen, and their depletion did not affect the bacterial burden in this organ, supporting a liver-specific action of Thy1.2 + cells in response to mycobacterial infection. We cannot exclude the possibility that the control of bacterial proliferation observed in Rag2 2/2 gc 2/2 mice might also rely on IFN-g-independent compensatory mechanisms such as TNF production. In the spleen, Thy1.2 + /non-NK cells produce minute amounts of IFN-g, suggesting the involvement of another protective mechanism. The fact that Thy1.2 depletion in the infected Rag2 2/2 gc 2/2 animals did not affect the bacterial proliferation control in the spleens also supports this hypothesis. It is still possible that other cells may secrete IFN-g and compensate for the removal of these CD45 + Thy1.2 + non-NK, nonmyeloid cells in the spleen. Macrophages, dendritic cells, or PMNs may be responsible for the splenic production of IFN-g as described in other infection models (18) (19) (20) (21) . However, we failed to detect such cytokine production in these myeloid cells by either the use of reporter mice or by qPCR of sorted populations. The regulation of IFN-g expression in these cells is likely different and not constitutive, as is found in ILCs. Thus, the lack of detection in myeloid cells by qPCR may relate to inadequate triggering stimuli or kinetic constraints.
Taken together, our study reveals a unique subset of innate IFNg-producing cells that develops in the absence of IL-2R common gc. The lower amounts of IFN-g expressed by cells other than T cells, NK cells, or other ILCs in the spleen compared with the liver may explain why these cells were never detected before. In addition, the majority of the studies exploring in vivo responses to infection and the specific role of different cell populations have been done with spleen cells. In fact, there are very few studies exploring the different liver cell populations using flow cytometry and, to our knowledge, this is the first work to unveil the cellular expression of IFN-g by nonconventional cells in the liver. Thus, our work has identified a new cell subset capable of producing IFN-g constitutively and with a protective role toward M. avium infection in an immune-compromised mouse model.
